Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-24-000069 General Corporate
Debt relative to revenue 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
127.90% · OPTIONAL · VALID
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.25% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.41% · OPTIONAL · VALID
Revenue growth 15th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-1.86% · CORE · VALID
Inventory pressure 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
55.89% · OPTIONAL · VALID
Operating margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
8.90% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.33% · OPTIONAL · VALID
SBC intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.60% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 134.21%
Current 127.90%
Delta -6.31% Capex Intensity Increased
Previous 5.72%
Current 7.25%
Delta 1.53% Cash Generation Increased
Previous -6.41%
Current 19.41%
Delta 25.81% Growth Increased
Previous -1.99%
Current -1.86%
Delta 0.13% Inventory Pressure Decreased
Previous 61.43%
Current 55.89%
Delta -5.54% Profitability Increased
Previous 5.85%
Current 8.90%
Delta 3.05% R And D Intensity Increased
Previous 2.03%
Current 2.33%
Delta 0.30% Sbc Intensity Decreased
Previous 1.14%
Current 0.60%
Delta -0.54% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.